FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

704259004: Ramucirumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3011387018 Ramucirumab en Synonym Active Entire term case insensitive SNOMED CT core module
3011432018 Ramucirumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ramucirumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Ramucirumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Ramucirumab Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Existential restriction modifier
Ramucirumab Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Ramucirumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ramucirumab Has active ingredient True Ramucirumab Inferred relationship Existential restriction modifier 1
Ramucirumab 10mg/mL solution for intravenous infusion Has active ingredient False Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 10mg/mL conventional release solution for injection Has active ingredient False Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab Has active ingredient True Ramucirumab Inferred relationship Existential restriction modifier 1
Product containing ramucirumab in parenteral dose form (medicinal product form) Has active ingredient True Ramucirumab Inferred relationship Existential restriction modifier 1
Product containing only ramucirumab in parenteral dose form (medicinal product form) Has active ingredient True Ramucirumab Inferred relationship Existential restriction modifier 1
Product containing precisely ramucirumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ramucirumab Inferred relationship Existential restriction modifier 1
Product containing precisely ramucirumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Ramucirumab Inferred relationship Existential restriction modifier 1
Ramucirumab 500mg/50ml solution for infusion vials Has active ingredient False Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 100mg/10ml solution for infusion vials Has active ingredient False Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 500mg/50ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 500mg/50ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 100mg/10ml solution for infusion vials Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 500mg/50ml solution for infusion vials Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 500mg/50ml solution for infusion vials 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Ramucirumab 100mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient True Ramucirumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start